Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD
Sponsor: Korro Bio, Inc.
Summary
Phase 1/2 Study of KRRO-121 is a randomized, placebo-controlled study in Healthy Volunteers (Phase 1 SAD and MAD) and Study Participants with Urea Cycle Disorders (Phase 2). The primary objective of the study is to evaluate the safety of KRRO-121.
Official title: A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of KRRO-121 in Healthy Volunteers and Patients With Urea Cycle Disorders
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-09
Completion Date
2027-09
Last Updated
2026-08-19
Healthy Volunteers
Yes
Conditions
Interventions
KRRO-121
KRRO-121, subcutaneous injection
Placebo
Placebo, subcutaneous injection
Locations (1)
Nucleus Network Pty Ltd
Melbourne, Victoria, Australia